CITIGROUP INC - ENTRADA THERAPEUTICS INC ownership

ENTRADA THERAPEUTICS INC's ticker is and the CUSIP is 29384C108. A total of 47 filers reported holding ENTRADA THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.

Quarter-by-quarter ownership
CITIGROUP INC ownership history of ENTRADA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$490
-99.5%
31
-99.5%
0.00%
Q2 2023$100,878
-88.8%
6,663
-89.3%
0.00%
-100.0%
Q1 2023$899,334
+30.3%
62,023
+21.5%
0.00%0.0%
Q4 2022$690,088
+2660.4%
51,042
+3124.4%
0.00%
Q3 2022$25,000
+2400.0%
1,583
+1584.0%
0.00%
Q2 2022$1,000
-75.0%
94
-77.2%
0.00%
Q1 2022$4,000
-90.2%
413
-82.7%
0.00%
Q4 2021$41,0002,3930.00%
Other shareholders
ENTRADA THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
MPM ASSET MANAGEMENT LLC 4,425,784$69,750,00026.57%
5AM Venture Management, LLC 4,408,379$69,476,00013.31%
72 Investment Holdings, LLC 509,023$8,022,0006.36%
TCG Crossover Management, LLC 642,189$10,121,0003.04%
StepStone Group LP 761,277$11,998,0001.71%
Nan Fung Group Holdings Ltd 141,593$2,232,0001.42%
Redmile Group, LLC 1,954,419$30,802,0001.20%
Baker Brothers Advisors 4,865,819$76,685,0000.50%
MOORE CAPITAL MANAGEMENT, LP 105,000$1,655,0000.04%
Laurion Capital Management LP 199,066$3,137,0000.02%
View complete list of ENTRADA THERAPEUTICS INC shareholders